{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:18:04Z","timestamp":1772723884262,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rcsop.2026.100709","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:34:11Z","timestamp":1769470451000},"page":"100709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence"],"prefix":"10.1016","volume":"21","author":[{"given":"Shreya","family":"Shiju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Tirumala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Marseille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2026.100709_bb0005","series-title":"Results from the 2015 National Survey on Drug Use and Health: Detailed tables","author":"Center for Behavioral Health Statistics and Quality","year":"2016"},{"key":"10.1016\/j.rcsop.2026.100709_bb0010","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100709_bb0015","first-page":"50","article-title":"Psychedelics as medicine","volume":"55","year":"2024","journal-title":"APA Monit."},{"issue":"5","key":"10.1016\/j.rcsop.2026.100709_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.26719\/2011.17.5.409","article-title":"Self-medication practice among patients in a public health care system","volume":"17","author":"Alghanim","year":"2011","journal-title":"East Mediterr Health J"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100709_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv Rev Psychiatry"},{"issue":"8","key":"10.1016\/j.rcsop.2026.100709_bb0030","first-page":"1793","article-title":"Motives for the use of serotonergic psychedelics: a systematic review","volume":"41","author":"Basedow","year":"2022","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100709_bb0035","first-page":"337","article-title":"Use of psychedelics for pain: a scoping review","volume":"139","author":"Goel","year":"2023","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100709_bb0040","first-page":"286","article-title":"Are psychedelics the answer to chronic pain? A review of current literature","volume":"23","author":"Kooijman","year":"2023","journal-title":"Pain Pract"},{"issue":"4","key":"10.1016\/j.rcsop.2026.100709_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.rcsop.2026.100709_bb0050","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"de Vos","year":"2021","journal-title":"Front Psych"},{"key":"10.1016\/j.rcsop.2026.100709_bb0055","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","author":"Inserra","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.rcsop.2026.100709_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1526-4610.2011.02028.x","article-title":"Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden","volume":"52","author":"Rozen","year":"2012","journal-title":"Headache"},{"issue":"11","key":"10.1016\/j.rcsop.2026.100709_bb0065","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.rcsop.2026.100709_bb0070","article-title":"Therapeutic effects of psychedelics for opioid use disorder: a systematic review","volume":"335","author":"Bogenschutz","year":"2023","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.rcsop.2026.100709_bb0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"5","key":"10.1016\/j.rcsop.2026.100709_bb0080","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/0333102418804160","article-title":"Increased use of illicit drugs in a Dutch cluster headache population","volume":"39","author":"de Coo","year":"2019","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.rcsop.2026.100709_bb0085","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.wnl.0000219761.05466.43","article-title":"Response of cluster headache to psilocybin and LSD","volume":"66","author":"Sewell","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.rcsop.2026.100709_bb0090","author":"Ballotpedia"},{"key":"10.1016\/j.rcsop.2026.100709_bb0095","author":"Oregon Health Authority"},{"key":"10.1016\/j.rcsop.2026.100709_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.4928","article-title":"Gaps in US psychedelic policy and how to close them","author":"Propes","year":"2025","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.rcsop.2026.100709_bb0105","author":"Fireside Project"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276626000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:16:11Z","timestamp":1772720171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276626000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"alternative-id":["S2667276626000077"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100709","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2026.100709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100709"}}